• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[促性腺激素治疗期间通过测定血清和尿液中的雌激素来控制卵泡成熟]

[Control of follicle maturation by estrogen determination in the serum and urine during treatment with gonadotropins].

作者信息

Seifert B, Hassler M P, Helbing W

出版信息

Zentralbl Gynakol. 1983;105(8):482-6.

PMID:6408837
Abstract

Determinations of estrogen concentration in urine or serum for estimation of follicle maturity is a precondition for treatment with gonadotropines. -- Both methods determination are retrospectively compared in 22 cases. Only the RIA-method of 17 beta-estradiol determination is capable to recognize an overstimulation with a high rate of reliability, because the evidence of total estrogens in urine lags behind. Clinical tests such as Insler-score don't indicate chemical overstimulation.

摘要

测定尿液或血清中的雌激素浓度以评估卵泡成熟度是使用促性腺激素治疗的前提条件。——对22例患者的两种测定方法进行回顾性比较。只有17β-雌二醇的放射免疫分析方法能够以高可靠性识别过度刺激,因为尿液中总雌激素的检测滞后。像Insler评分这样的临床检查并不能表明化学性过度刺激。

相似文献

1
[Control of follicle maturation by estrogen determination in the serum and urine during treatment with gonadotropins].[促性腺激素治疗期间通过测定血清和尿液中的雌激素来控制卵泡成熟]
Zentralbl Gynakol. 1983;105(8):482-6.
2
[Gonadotropin treatment in corpus luteum insufficiency-induced functional sterility].[促性腺激素治疗黄体功能不全所致功能性不育]
Zentralbl Gynakol. 1983;105(11):681-6.
3
Therapy of ovulatory sterility and corpus luteum insufficiency with human menopausal and chorionic gonadotropins.用人绝经期促性腺激素和绒毛膜促性腺激素治疗排卵性不育症和黄体功能不全。
Isr J Med Sci. 1971 Sep;7(9):1040-5.
4
[Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
Fortschr Med. 1981 Jul 23;99(27-28):1080-6.
5
Induction of ovulation with human postmenopausal gonadotropin. 3. Effect of varying dosage schedules on estrogen and pregnanediol excretion levels.
Fertil Steril. 1967 Mar-Apr;18(2):181-90. doi: 10.1016/s0015-0282(16)36242-2.
6
Induction of ovulation in polycystic ovarian disease.
Prog Clin Biol Res. 1986;225:401-12.
7
[Course of pregnancy after ovarian stimulation with gonadotropin].[使用促性腺激素进行卵巢刺激后的妊娠过程]
Zentralbl Gynakol. 1970 Apr 4;92(14):417-9.
8
The monitoring of gonadotrophin therapy by plasma oestradiol and progesterone determinations.通过测定血浆雌二醇和孕酮来监测促性腺激素治疗。
J Obstet Gynaecol Br Commonw. 1974 Sep;81(9):657-66. doi: 10.1111/j.1471-0528.1974.tb00537.x.
9
Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.在世界卫生组织II组无排卵女性中起始剂量为50国际单位重组促卵泡激素的促排卵治疗:IO-50研究,一项前瞻性、观察性、多中心、开放性试验
BJOG. 2003 Dec;110(12):1072-7.
10
Recombinant gonadotropins.重组促性腺激素
Curr Womens Health Rep. 2001 Oct;1(2):157-63.